Louise Kooij

Louise Kooij

Comptroller/Controller/Auditor at FRAZIER LIFESCIENCES ACQUISITION CORPORATION

Net worth: 79 249 $ as of 31/05/2026

50 year
Health Technology
Distribution Services
Consumer Services

Profile

Louise Kooij is currently Chief Accounting Officer at NewAmsterdam Pharma Co. NV since 2023.
Formerly, Ms. Kooij was Head-Finance & Operations at Azafaros BV from 2020 to 2023, Head-Rare Disease at Genzyme Therapeutics Ltd. from 2018 to 2020, Product Group Accountant at Hagemeyer NV, and Auditor at PricewaterhouseCoopers BV.
Ms. Kooij graduated from Nyenrode Business Universiteit.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
22/06/2026 2,353 ( 0% ) 79 249 $ 31/05/2026

Louise Kooij active positions

CompaniesPositionStart
FRAZIER LIFESCIENCES ACQUISITION CORPORATION Comptroller/Controller/Auditor 01/01/2023

Former positions of Louise Kooij

CompaniesPositionEnd
Director of Finance/CFO 21/03/2023
Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal -
Comptroller/Controller/Auditor -
See the detail of Louise Kooij's experience

Training of Louise Kooij

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

2

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Distribution Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology